Moreover, it has been reported that EGCG selectively inhibited IL-1β-induced IL-6 synthesis in RA synovial fibroblasts and suppressed IL-6 trans-signaling via upregulation of an endogenous inhibitor, a soluble gp130 [123]. The gene discussed is IL1B; the disease is rheumatoid arthritis.